Skip to main content

Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use

Nov 08, 2023 4:00 pm
Social Author Name
Dr. John Cush
Tweet Content
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions. https://t.co/MRFwrCXIlQ https://t.co/Su3nMs4CNW
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×